Latest Insider Transactions at Willis Towers Watson PLC (WTW)
This section provides a real-time view of insider transactions for Willis Towers Watson PLC (WTW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of WILLIS TOWERS WATSON PLC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of WILLIS TOWERS WATSON PLC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Payment of exercise price or tax liability
|
Direct |
114
-0.11%
|
$25,650
$225.61 P/Share
|
|
Feb 22
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
4,525
+4.33%
|
-
|
|
Feb 22
2022
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
3,480
+11.89%
|
-
|
|
Feb 22
2022
|
Adam Garrard Head of Risk & Broking |
BUY
Grant, award, or other acquisition
|
Direct |
3,274
+20.33%
|
-
|
|
Feb 22
2022
|
Anne Donovan Bodnar Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
82
-0.57%
|
$18,450
$225.61 P/Share
|
|
Feb 22
2022
|
Anne Donovan Bodnar Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,958
+16.96%
|
-
|
|
Feb 22
2022
|
Anne Donovan Bodnar Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
2,000
-5.16%
|
$446,000
$223.9 P/Share
|
|
Feb 14
2022
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Open market or private sale
|
Direct |
2,400
-2.45%
|
$528,000
$220.99 P/Share
|
|
Jan 03
2022
|
Michelle R Swanback Director |
BUY
Grant, award, or other acquisition
|
Direct |
283
+50.0%
|
-
|
|
Jan 03
2022
|
Michael P. Hammond Director |
BUY
Grant, award, or other acquisition
|
Direct |
283
+50.0%
|
-
|
|
Jan 03
2022
|
Inga K Beale Director |
BUY
Grant, award, or other acquisition
|
Direct |
283
+50.0%
|
-
|
|
Jan 03
2022
|
Victor F Ganzi Director |
BUY
Grant, award, or other acquisition
|
Direct |
265
+1.17%
|
-
|
|
Dec 31
2021
|
John J Haley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,012
-0.29%
|
$239,844
$237.49 P/Share
|
|
Dec 31
2021
|
John J Haley Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,570
+0.72%
|
-
|
|
Dec 29
2021
|
Jaymin B Patel Director |
SELL
Payment of exercise price or tax liability
|
Direct |
291
-5.09%
|
$69,258
$238.72 P/Share
|
|
Dec 29
2021
|
John J Haley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,373
-4.98%
|
$4,372,774
$238.72 P/Share
|
|
Dec 29
2021
|
John J Haley Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
46,688
+11.24%
|
-
|
|
Dec 03
2021
|
John J Haley Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
28,900
-69.04%
|
$6,675,900
$231.97 P/Share
|
|
Dec 03
2021
|
John J Haley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
102,409
-12.82%
|
$23,758,888
$232.85 P/Share
|
|
Dec 03
2021
|
John J Haley Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
150,235
+26.15%
|
$16,525,850
$110.58 P/Share
|
|
Nov 15
2021
|
Anne Pullum Head of Europe |
SELL
Sale (or disposition) back to the issuer
|
Direct |
410
-3.88%
|
$94,300
$230.91 P/Share
|
|
Nov 15
2021
|
Anne Pullum Head of Europe |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
40
+0.38%
|
-
|
|
Nov 15
2021
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Sale (or disposition) back to the issuer
|
Direct |
42,010
-16.22%
|
$9,620,290
$229.73 P/Share
|
|
Nov 15
2021
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Exercise of conversion of derivative security
|
Direct |
42,010
+23.11%
|
$4,621,100
$110.58 P/Share
|
|
Nov 02
2021
|
Adam Garrard Head of Risk & Broking |
SELL
Open market or private sale
|
Direct |
110
-1.14%
|
$26,180
$238.53 P/Share
|
|
Nov 01
2021
|
Adam Garrard Head of Risk & Broking |
SELL
Open market or private sale
|
Direct |
6,000
-38.3%
|
$1,416,000
$236.36 P/Share
|
|
Oct 01
2021
|
Joseph Stephen Kurpis PAO and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
311
+50.0%
|
-
|
|
Sep 07
2021
|
Andrew Jay Krasner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,210
+49.07%
|
-
|
|
Aug 18
2021
|
Gene H Wickes Head of Benefits Deliv & Admin |
BUY
Bona fide gift
|
Indirect |
1,300
+19.22%
|
-
|
|
Aug 18
2021
|
Gene H Wickes Head of Benefits Deliv & Admin |
SELL
Bona fide gift
|
Direct |
2,121
-1.49%
|
-
|
|
Jul 20
2021
|
Carl Aaron Hess Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,140
-8.66%
|
$894,240
$216.09 P/Share
|
|
Jul 20
2021
|
Nicolas Aubert Head of Great Britain |
SELL
Payment of exercise price or tax liability
|
Direct |
3,627
-18.01%
|
$783,432
$216.09 P/Share
|
|
Jul 20
2021
|
Adam Garrard Head of Risk & Broking |
SELL
Payment of exercise price or tax liability
|
Direct |
2,548
-13.99%
|
$550,368
$216.09 P/Share
|
|
Jul 20
2021
|
Matthew Furman General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,556
-13.74%
|
$768,096
$216.09 P/Share
|
|
Jul 20
2021
|
Michael J Burwell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,085
-17.9%
|
$1,098,360
$216.09 P/Share
|
|
Jul 20
2021
|
Joseph Gunn Head of North America |
SELL
Payment of exercise price or tax liability
|
Direct |
1,934
-7.54%
|
$417,744
$216.09 P/Share
|
|
Jul 20
2021
|
Anne Pullum Head of Europe |
SELL
Payment of exercise price or tax liability
|
Direct |
1,656
-13.6%
|
$357,696
$216.09 P/Share
|
|
Jul 20
2021
|
Gene H Wickes Head of Benefits Deliv & Admin |
SELL
Payment of exercise price or tax liability
|
Direct |
2,781
-3.73%
|
$600,696
$216.09 P/Share
|
|
Jul 20
2021
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
SELL
Payment of exercise price or tax liability
|
Direct |
3,388
-3.35%
|
$731,808
$216.09 P/Share
|
|
Jul 20
2021
|
Anne Donovan Bodnar Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,581
-10.46%
|
$341,496
$216.09 P/Share
|
|
Jun 15
2021
|
Anne Donovan Bodnar Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.09%
|
-
|
|
Jun 15
2021
|
Michael J Burwell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35
+0.12%
|
-
|
|
Jun 15
2021
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
17
+0.07%
|
-
|
|
Jun 15
2021
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.02%
|
-
|
|
Jun 15
2021
|
Joseph Gunn Head of North America |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.05%
|
-
|
|
Jun 15
2021
|
Carl Aaron Hess Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21
+0.04%
|
-
|
|
Jun 15
2021
|
Gene H Wickes Head of Benefits Deliv & Admin |
BUY
Grant, award, or other acquisition
|
Direct |
22
+0.03%
|
-
|
|
Jun 15
2021
|
Anne Pullum Head of Europe |
BUY
Grant, award, or other acquisition
|
Direct |
14
+0.11%
|
-
|
|
Jun 15
2021
|
Nicolas Aubert Head of Great Britain |
BUY
Grant, award, or other acquisition
|
Direct |
21
+0.1%
|
-
|
|
May 11
2021
|
Anna C Catalano Director |
BUY
Grant, award, or other acquisition
|
Direct |
605
+8.81%
|
-
|